BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1863 related articles for article (PubMed ID: 32299382)

  • 21. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
    Liu M; Zhu K; Qian X; Li W
    Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrative analysis of mRNA and miRNA expression profiles reveals seven potential diagnostic biomarkers for non‑small cell lung cancer.
    Zhang J; Li D; Zhang Y; Ding Z; Zheng Y; Chen S; Wan Y
    Oncol Rep; 2020 Jan; 43(1):99-112. PubMed ID: 31746439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of the circRNA-miRNA-mRNA Regulatory Network of an Abdominal Aortic Aneurysm to Explore Its Potential Pathogenesis.
    Zhang H; Bian C; Tu S; Yin F; Guo P; Zhang J; Wu Y; Yin Y; Guo J; Han Y
    Dis Markers; 2021; 2021():9916881. PubMed ID: 34777635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated Bioinformatics Analysis of mRNAs and miRNAs Identified Potential Biomarkers of Oral Squamous Cell Carcinoma.
    Amiri-Dashatan N; Koushki M; Jalilian A; Ahmadi NA; Rezaei-Tavirani M
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1841-1848. PubMed ID: 32597160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
    Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
    Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive analysis of non-small-cell lung cancer microarray datasets identifies several prognostic biomarkers.
    Qin X; Chen R; Xiong R; Tan Z; Gao S; Lin C; Huo T
    Future Oncol; 2019 Sep; 15(27):3135-3148. PubMed ID: 31426680
    [No Abstract]   [Full Text] [Related]  

  • 27. Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis.
    Cheng Q; Chen X; Wu H; Du Y
    J Transl Med; 2021 Jan; 19(1):18. PubMed ID: 33407587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of lncRNA TYMSOS/hsa-miR-101-3p/CEP55 and TYMSOS/hsa-miR-195-5p/CHEK1 Axis in Non-small Cell Lung Cancer.
    Ji L; Yang T; Liu M; Li J; Si Q; Wang Y; Liu J; Dai L
    Biochem Genet; 2023 Jun; 61(3):995-1014. PubMed ID: 36352081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of key miRNAs and mRNAs related to coronary artery disease by meta-analysis.
    Liu L; Zhang J; Wu M; Xu H
    BMC Cardiovasc Disord; 2021 Sep; 21(1):443. PubMed ID: 34530741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated Analysis of Competing Endogenous RNAs Network Reveals Potential Signatures in Osteosarcoma Development.
    Heng L; Jia Z; Sun J; Zhao Y; Zhang K; Zhu Y; Lu S
    Technol Cancer Res Treat; 2020; 19():1533033820957025. PubMed ID: 32912111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
    Luo ZB; Lai GE; Jiang T; Cao CL; Peng T; Liu FE
    Technol Cancer Res Treat; 2020; 19():1533033820983293. PubMed ID: 33371806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The
    Xu G; Mo L; Wu C; Shen X; Dong H; Yu L; Pan P; Pan K
    Ren Fail; 2019 Nov; 41(1):955-966. PubMed ID: 31658856
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification of carcinogenic potential-associated molecular mechanisms in CD133(+) A549 cells based on microRNA profiles.
    Chen QY; Jiao DM; Zhu Y; Hu H; Wang J; Tang X; Chen J; Yan L
    Tumour Biol; 2016 Jan; 37(1):521-30. PubMed ID: 26227219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.
    Meng Y; Quan L; Liu A
    Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construct a circRNA/miRNA/mRNA regulatory network to explore potential pathogenesis and therapy options of clear cell renal cell carcinoma.
    Bai S; Wu Y; Yan Y; Shao S; Zhang J; Liu J; Hui B; Liu R; Ma H; Zhang X; Ren J
    Sci Rep; 2020 Aug; 10(1):13659. PubMed ID: 32788609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA XIST serves as a ceRNA to regulate the expression of ASF1A, BRWD1M, and PFKFB2 in kidney transplant acute kidney injury via sponging hsa-miR-212-3p and hsa-miR-122-5p.
    Cheng Q; Wang L
    Cell Cycle; 2020 Feb; 19(3):290-299. PubMed ID: 31914881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer.
    Chacon-Millan P; Lama S; Del Gaudio N; Gravina AG; Federico A; Pellegrino R; Luce A; Altucci L; Facchiano A; Caraglia M; Stiuso P
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of key miRNAs and target genes in bladder cancer using miRNA profiling and bioinformatic tools.
    Canturk KM; Ozdemir M; Can C; Öner S; Emre R; Aslan H; Cilingir O; Ciftci E; Celayir FM; Aldemir O; Özen M; Artan S
    Mol Biol Rep; 2014 Dec; 41(12):8127-35. PubMed ID: 25189652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
    Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
    World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 94.